These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 33484965)
1. A versatile platform for generating engineered extracellular vesicles with defined therapeutic properties. Dooley K; McConnell RE; Xu K; Lewis ND; Haupt S; Youniss MR; Martin S; Sia CL; McCoy C; Moniz RJ; Burenkova O; Sanchez-Salazar J; Jang SC; Choi B; Harrison RA; Houde D; Burzyn D; Leng C; Kirwin K; Ross NL; Finn JD; Gaidukov L; Economides KD; Estes S; Thornton JE; Kulman JD; Sathyanarayanan S; Williams DE Mol Ther; 2021 May; 29(5):1729-1743. PubMed ID: 33484965 [TBL] [Abstract][Full Text] [Related]
2. Creating Designer Engineered Extracellular Vesicles for Diverse Ligand Display, Target Recognition, and Controlled Protein Loading and Delivery. Ivanova A; Badertscher L; O'Driscoll G; Bergman J; Gordon E; Gunnarsson A; Johansson C; Munson MJ; Spinelli C; Torstensson S; Vilén L; Voirel A; Wiseman J; Rak J; Dekker N; Lázaro-Ibáñez E Adv Sci (Weinh); 2023 Dec; 10(34):e2304389. PubMed ID: 37867228 [TBL] [Abstract][Full Text] [Related]
3. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles. Nasiri Kenari A; Cheng L; Hill AF Methods; 2020 May; 177():103-113. PubMed ID: 31917274 [TBL] [Abstract][Full Text] [Related]
4. TOP-EVs: Technology of Protein delivery through Extracellular Vesicles is a versatile platform for intracellular protein delivery. Ilahibaks NF; Ardisasmita AI; Xie S; Gunnarsson A; Brealey J; Vader P; de Jong OG; de Jager S; Dekker N; Peacock B; Schiffelers RM; Sluijter JPG; Lei Z J Control Release; 2023 Mar; 355():579-592. PubMed ID: 36746337 [TBL] [Abstract][Full Text] [Related]
5. Identification of scaffold proteins for improved endogenous engineering of extracellular vesicles. Zheng W; Rädler J; Sork H; Niu Z; Roudi S; Bost JP; Görgens A; Zhao Y; Mamand DR; Liang X; Wiklander OPB; Lehto T; Gupta D; Nordin JZ; El Andaloussi S Nat Commun; 2023 Aug; 14(1):4734. PubMed ID: 37550290 [TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicle surface display of αPD-L1 and αCD3 antibodies via engineered late domain-based scaffold to activate T-cell anti-tumor immunity. Chen R; Kang Z; Li W; Xu T; Wang Y; Jiang Q; Wang Y; Huang Z; Xu X; Huang Z J Extracell Vesicles; 2024 Jul; 13(7):e12490. PubMed ID: 39051742 [TBL] [Abstract][Full Text] [Related]
7. Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading. Sutaria DS; Badawi M; Phelps MA; Schmittgen TD Pharm Res; 2017 May; 34(5):1053-1066. PubMed ID: 28315083 [TBL] [Abstract][Full Text] [Related]
8. Cell Surface Labeling by Engineered Extracellular Vesicles. Hamilton N; Claudio NM; Armstrong RJ; Pucci F Adv Biosyst; 2020 Dec; 4(12):e2000007. PubMed ID: 32390342 [TBL] [Abstract][Full Text] [Related]
9. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery. Hung ME; Leonard JN J Extracell Vesicles; 2016; 5():31027. PubMed ID: 27189348 [TBL] [Abstract][Full Text] [Related]
10. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles. Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585 [TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation. Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296 [TBL] [Abstract][Full Text] [Related]
12. Production of Extracellular Vesicles Loaded with Therapeutic Cargo. Lamichhane TN; Jay SM Methods Mol Biol; 2018; 1831():37-47. PubMed ID: 30051423 [TBL] [Abstract][Full Text] [Related]
13. Engineered extracellular vesicles and their mimetics for clinical translation. Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB Methods; 2020 May; 177():80-94. PubMed ID: 31626895 [TBL] [Abstract][Full Text] [Related]
14. Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles. O'Loughlin AJ; Mäger I; de Jong OG; Varela MA; Schiffelers RM; El Andaloussi S; Wood MJA; Vader P Mol Ther; 2017 Jul; 25(7):1580-1587. PubMed ID: 28392161 [TBL] [Abstract][Full Text] [Related]
15. Chinese hamster ovary cell line engineering strategies for modular production of custom extracellular vesicles. Carrillo Sanchez B; Hinchliffe M; Ellis M; Simpson C; Humphreys D; Sweeney B; Bracewell DG Biotechnol Bioeng; 2024 Sep; 121(9):2907-2923. PubMed ID: 38924052 [TBL] [Abstract][Full Text] [Related]
16. Enhancing extracellular vesicle cargo loading and functional delivery by engineering protein-lipid interactions. Peruzzi JA; Gunnels TF; Edelstein HI; Lu P; Baker D; Leonard JN; Kamat NP Nat Commun; 2024 Jul; 15(1):5618. PubMed ID: 38965227 [TBL] [Abstract][Full Text] [Related]
17. The cell type dependent sorting of CD9- and CD81 to extracellular vesicles can be exploited to convey tumor sensitive cargo to target cells. Zuppone S; Zarovni N; Vago R Drug Deliv; 2023 Dec; 30(1):2162161. PubMed ID: 36579638 [TBL] [Abstract][Full Text] [Related]
18. Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles. Iraci N; Leonardi T; Gessler F; Vega B; Pluchino S Int J Mol Sci; 2016 Feb; 17(2):171. PubMed ID: 26861302 [TBL] [Abstract][Full Text] [Related]
20. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology. Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]